IMCAS Paris 2025 industry symposium
IMCAS Paris 2025: Hot Topics and Trends from the Conference

IMCAS Paris 2025 has once again set the stage for groundbreaking advancements in aesthetic medicine, bringing together top experts, innovators, and industry leaders from around the world.

An individual receiving an injection into a patient's upper face region.
NCTF 135 HA vs Profhilo – Comparing Dermal Fillers

Minimally invasive treatments, particularly hyaluronic acid-based injectables, have gained widespread popularity due to their effectiveness and minimal downtime.

A close-up shot of an older person's under eye aging signs.
NCTF 135 HA Under Eye – Target Fine Lines and Wrinkles

The under-eye area is one of the first to show signs of aging, with dark circles, fine lines, and hollowness contributing to a tired appearance.

A scientist working on an injection formulation.
NCTF 135 HA Ingredients – Hyaluronic Acid, 12 Vitamins, 24 Amino Acids

Aesthetic skin boosters, particularly those formulated with hyaluronic acid, have been proven to enhance skin hydration, boost elasticity, and reduce the appearance of wrinkles.

An individual undergoing a microinjection session on their facial region.
NCTF 135 HA Reviews – Patient and Practitioner Feedback

Patient and practitioner reviews play a crucial role in evaluating the effectiveness of aesthetic treatments.

An individual checking their face in the mirror.
NCTF 135 HA Side Effects – A Complete List

Did you know that 70% of consumers choose cosmetic procedures to boost their confidence and maintain a youthful appearance?

A patient showing off their before and after improvement.
NCTF 135 HA Before And After – With Photo Examples

Did you know that 83% of patients researching aesthetic procedures wouldn’t consider a practice without a before-and-after gallery?

Two injections on a surface.
Cimzia vs Enbrel – Comparing Two TNF-Alpha Inhibitors

A study published in the International Journal of Molecular Sciences highlights the crucial role of TNF-alpha inhibitors in managing autoimmune diseases.

An individual suffering from abdominal pain.
Cimzia for Crohn’s Disease – Effective Treatment for Inflammatory Bowel Disease

Crohn’s disease affects millions of adults in the United States, with prevalence rates estimated between 2.4 and 3.1 million, according to the Centers for Disease Control and Prevention (CDC).

A scientist checking the medical laboratory during a formulation's production.
Cimzia Manufacturer – About UCB

Autoimmune disorders affect one in ten people, making them a growing global health concern.

A medical professional preparing the syringe for injection.
Cimzia Indications – Approved Uses for Cimzia in Autoimmune Disorders

The FDA requires that the Indications and Usage section of drug labeling clearly defines a medication’s intended purpose—whether for treatment, prevention, mitigation, cure, diagnosis, or symptom relief.

An injection syringe and vial on a surface.
Cimzia Mechanism of Action – How It Works to Treat Autoimmune Conditions

Autoimmune diseases affect approximately 10 million people in the United States, accounting for about 3% of the population.